Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Model may predict prolonged status epilepticus outcomes
- Author:
- Jeff Evans
Publish date: November 30, 2018
News
ACR forges ahead with physician-focused APM for RA
- Author:
- Jeff Evans
Publish date: November 9, 2018
News
Funding for NIH BRAIN Initiative reaches new heights
- Author:
- Jeff Evans
Publish date: November 2, 2018
News

Bills affecting rheumatologists make way to Capitol Hill
- Author:
- Jeff Evans
Publish date: October 24, 2018
News
3-D model neurovascular unit developed with working blood-brain barrier
- Author:
- Jeff Evans
Publish date: October 13, 2018
News
Studies reveal pregnancy trends in American women with MS
- Author:
- Jeff Evans
Publish date: October 5, 2018
News
Hot topic explores neuropathologic differences between MS individuals
- Author:
- Jeff Evans
Publish date: October 4, 2018
News

Benign MS is real in small minority of patients
- Author:
- Jeff Evans
Publish date: September 7, 2018
News
Noninferiority endpoint not met between Xeljanz formulations for RA
- Author:
- Jeff Evans
Publish date: August 21, 2018
News

Cost of medical care for older adults with epilepsy steadily grows
- Author:
- Jeff Evans
Publish date: June 22, 2018
Audio

MS drugs in Medicare Part D: Higher tiers, less coverage, more prior authorizations
- Author:
- Jeff Evans
Publish date: April 27, 2018
Video

VIDEO: Meeting stroke screening demand will require systems’ reorganization
- Author:
- Jeff Evans
Publish date: April 26, 2018
Video

VIDEOS: High-priced drugs, out-of-pocket costs raise challenges for neurologists
- Author:
- Jeff Evans
Publish date: April 24, 2018
News

Real-world data so far support pimavanserin trial results
- Author:
- Jeff Evans
Publish date: April 24, 2018
News

Blood-brain barrier health may signal early loss of MS treatment response
- Author:
- Jeff Evans
Publish date: April 20, 2018